Chandra Bhan1, Pankaj Dipankar1, Papiya Chakraborty1, Pranita P Sarangi2. 1. Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee, 247667, Uttarakhand, India. 2. Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee, 247667, Uttarakhand, India. psarafbt@iitr.ac.in.
Abstract
INTRODUCTION: Sepsis is a dysregulated host immune response due to an uncontrolled infection. It is a leading cause of mortality in adult intensive care units globally. When the host immune response induced against a local infection fails to contain it locally, it progresses to sepsis, severe sepsis, septic shock and death. METHOD: Literature survey was performed on the roles of different innate and adaptive immune cells in the development and progression of sepsis. Additionally, the effects of septic changes on reprogramming of different immune cells were also summarized to prepare the manuscript. FINDINGS: Scientific evidences to date suggest that the loss of balance between inflammatory and anti-inflammatory responses results in reprogramming of immune cell activities that lead to irreversible tissue damaging events and multi-organ failure during sepsis. Many surface receptors expressed on immune cells at various stages of sepsis have been suggested as biomarkers for sepsis diagnosis. Various immunomodulatory therapeutics, which could improve the functions of immune cells during sepsis, were shown to restore immunological homeostasis and improve survival in animal models of sepsis. CONCLUSION: In-depth and comprehensive knowledge on the immune cell activities and their correlation with severity of sepsis will help clinicians and scientists to design effective immunomodulatory therapeutics for treating sepsis.
INTRODUCTION:Sepsis is a dysregulated host immune response due to an uncontrolled infection. It is a leading cause of mortality in adult intensive care units globally. When the host immune response induced against a local infection fails to contain it locally, it progresses to sepsis, severe sepsis, septic shock and death. METHOD: Literature survey was performed on the roles of different innate and adaptive immune cells in the development and progression of sepsis. Additionally, the effects of septic changes on reprogramming of different immune cells were also summarized to prepare the manuscript. FINDINGS: Scientific evidences to date suggest that the loss of balance between inflammatory and anti-inflammatory responses results in reprogramming of immune cell activities that lead to irreversible tissue damaging events and multi-organ failure during sepsis. Many surface receptors expressed on immune cells at various stages of sepsis have been suggested as biomarkers for sepsis diagnosis. Various immunomodulatory therapeutics, which could improve the functions of immune cells during sepsis, were shown to restore immunological homeostasis and improve survival in animal models of sepsis. CONCLUSION: In-depth and comprehensive knowledge on the immune cell activities and their correlation with severity of sepsis will help clinicians and scientists to design effective immunomodulatory therapeutics for treating sepsis.
Authors: William F Carson; Karen A Cavassani; Toshihiro Ito; Matthew Schaller; Makoto Ishii; Yali Dou; Steven L Kunkel Journal: Eur J Immunol Date: 2010-04 Impact factor: 5.532
Authors: J F Bermejo-Martín; A Rodriguez-Fernandez; R Herrán-Monge; D Andaluz-Ojeda; A Muriel-Bombín; P Merino; M M García-García; R Citores; F Gandía; R Almansa; J Blanco Journal: J Intern Med Date: 2014-05-29 Impact factor: 8.989
Authors: Brian Badgwell; Robin Parihar; Cynthia Magro; Julie Dierksheide; Thomas Russo; William Edgar Carson Journal: Surgery Date: 2002-08 Impact factor: 3.982
Authors: Alexandra C Bolognese; Weng-Lang Yang; Laura W Hansen; Naomi-Liza Denning; Jeffrey M Nicastro; Gene F Coppa; Ping Wang Journal: Surgery Date: 2018-04-27 Impact factor: 4.348
Authors: Brice Fermier; Hélène Blasco; Emmanuel Godat; Cinzia Bocca; Joseph Moënne-Loccoz; Patrick Emond; Christian R Andres; Marc Laffon; Martine Ferrandière Journal: Metabolites Date: 2016-09-01
Authors: Nicholas Wisniewski; Galyna Bondar; Christoph Rau; Jay Chittoor; Eleanor Chang; Azadeh Esmaeili; Martin Cadeiras; Mario Deng Journal: BMC Med Genomics Date: 2017-08-29 Impact factor: 3.063